Substituted 8-arylquinoline phosphodiesterase-4 inhibitors

Details for Australian Patent Application No. 2001297603 (hide)

International Classifications

Event Publications

19 December 2002 Complete Application Filed

Priority application(s): 60/256,803 20.12.00 US

13 March 2003 Application Open to Public Inspection

Published as AU-B-2001297603

16 February 2006 Application Accepted

Published as AU-B-2001297603

16 March 2006 Assignment before Grant

Merck & Co., Inc.; Merck Frosst Canada & Co. The application has been assigned to Merck & Co., Inc.; Merck Frosst Canada Ltd. 2002

15 June 2006 Standard Patent Sealed

8 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.